FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides group of new compounds with general formula Nu-O-Fa wherein Nu is nucleoside or its analog including nitrogen base such as adenine, isanine, cytosine, uracyl, and thymine, and Fa is acyl of monounsaturated C18- or C20- omega-9-fatty acid in which fatty acid is esterified by 5-hydroxyl group of sugar moiety of nucleoside or by hydroxyl group of non-cyclic chain of nucleoside analog. Pharmaceutical composition containing compound I as active ingredient manifests antiviral activity. EFFECT: extended resource of antiviral drugs. 21 cl, 14 dwg, 22 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF HEMCYTABINE | 1998 |
|
RU2194711C2 |
MONOESTER COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2139884C1 |
DERIVATIVES OF 2-THIOURACIL WITH ANTIADENOVIRAL ACTIVITY | 2017 |
|
RU2670204C1 |
QUATERNARY AMMONIUM SALTS BASED ON DERIVATIVES OF VITAMIN B6 | 2015 |
|
RU2607522C1 |
INHIBITORS OF HIV INTEGRASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2002 |
|
RU2284315C2 |
SUBSTITUTED SPIRO ANDROSTENES-17, 6'[1,3,4]THIADIAZINES WITH ANTIVIRAL ACTIVITY | 2021 |
|
RU2750639C1 |
DERIVATIVES OF ARABINOFURANOSYLCYTOSINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1996 |
|
RU2165260C2 |
METHOD FOR INHIBITING TUMOR CELLS WITH NEW DERIVATIVES OF 3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDE | 2020 |
|
RU2746395C1 |
DERIVATIVES OF 1,4-DIOXIDE OF QUINOXALINE-2-CARBONITRILE INHIBITING TUMOUR CELLS GROWTH | 2016 |
|
RU2640304C1 |
PERYLENE TRIAZOLES - INHIBITORS OF REPRODUCTION OF TICK-BORNE ENCEPHALITIS VIRUS | 2017 |
|
RU2650880C1 |
Authors
Dates
1999-02-20—Published
1992-09-30—Filed